MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Research participants are not representative of the population age distribution of PD

A. Macleod, R. Henery, P. Nwajiugo, C. Counsell (Aberdeen, United Kingdom)

Meeting: 2017 International Congress

Abstract Number: 25

Keywords: Parkinsonism

Session Information

Date: Monday, June 5, 2017

Session Title: Epidemiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To describe the distribution of the age at onset in PD incidence studies and to compare this with the age of onset of published studies in PD.

Background: Most sources (e.g. textbooks, review articles, patient information) state that the mean age at onset in Parkinson’s disease (PD) is about 60. The only reliable way to identify the true age distribution in a population of PD is through population-based incidence studies, which aim to identify all new cases of PD in a defined population over a specific time period.

Methods: We performed a comprehensive systematic review to identify all incidence studies in PD. From identified studies, we extracted data relating to mean age at onset (or diagnosis) and age-specific incidence rates. We performed Der Simonian and Laird random-effects meta-analysis of mean age at inception (i.e. either onset or diagnosis). We also performed meta-analysis of age-specific incidence rates (in 10-year age bands) in studies published since 2000 and plotted a histogram to illustrate the average distribution of the age of incident PD. We subsequently documented the mean age at onset in all research studies in PD published over six months in Movement Disorders (July to September 2016), and compared this to the pooled mean age at inception from the identified incidence studies

Results: Twelve incidence studies reported data on the mean age at inception in PD. The pooled mean age was 69.3 (95% confidence interval 67.0–71.7) (figure 1) although major heterogeneity was present (I2 = 96.8%). Some of the heterogeneity may be due to differences between age at onset and age at diagnosis. There was greatest heterogeneity in the oldest age stratum suggesting that some of the heterogeneity may be due to underascertainment in the elderly. The distribution of the age at inception in PD is displayed in figure 2. Of 41 studies published in Movement Disorders during the stated time period, 31 published the mean age at onset. The mean mean age at onset in these studies was 59.1 (median 58.9).

Conclusions: The mean age at onset in PD is nearly 70 which is both about ten years older than usually stated and about 10 years older than the mean age at onset in research participants. Many published studies have therefore used unrepresentative patient groups. This selection bias may have an important impact on the accuracy research findings as well as generalisability and further research should assess its influence.

To cite this abstract in AMA style:

A. Macleod, R. Henery, P. Nwajiugo, C. Counsell. Research participants are not representative of the population age distribution of PD [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/research-participants-are-not-representative-of-the-population-age-distribution-of-pd/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/research-participants-are-not-representative-of-the-population-age-distribution-of-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley